{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:28:39Z","timestamp":1790148519642,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ijantimicag.2015.08.012","type":"journal-article","created":{"date-parts":[[2015,10,2]],"date-time":"2015-10-02T17:20:08Z","timestamp":1443806408000},"page":"642-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates"],"prefix":"10.1016","volume":"46","author":[{"given":"Elizabeth B.","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Raux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola C.","family":"Zucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Kirby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon B.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Eliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0095","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10096-009-0833-2","article-title":"Fosfomycin: an old, new friend?","volume":"29","author":"Popovic","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1128\/AAC.50.1.368-370.2006","article-title":"In vitro activity of fosfomycin against extended-spectrum-\u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures","volume":"50","author":"de Cueto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0115","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/AAC.01235-09","article-title":"In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and\/or colistin","volume":"54","author":"Endimiani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0120","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.02048-13","article-title":"Susceptibility of multiresistant Gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods","volume":"58","author":"Perdig\u00e3o-Neto","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ijantimicag.2009.10.019","article-title":"Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0130","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1128\/AAC.00349-11","article-title":"Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods","volume":"55","author":"Lu","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0135","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1128\/AAC.00721-09","article-title":"Susceptibility of urinary tract bacteria to fosfomycin","volume":"53","author":"Maraki","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0140","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1128\/AAC.00650-13","article-title":"Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and coresistance phenotype among recent Escherichia coli isolates from U.S. veterans","volume":"57","author":"Johnson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0145","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Document M100-S24","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jac\/dkl545","article-title":"Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae","volume":"59","author":"L\u00f3pez-Cerero","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0155","series-title":"Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline\u2014third edition. Document M23-A3","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0160","doi-asserted-by":"crossref","first-page":"17786","DOI":"10.1074\/jbc.M501052200","article-title":"Functional analysis of active site residues of the fosfomycin resistance enzyme FosA from Pseudomonas aeruginosa","volume":"280","author":"Beharry","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0165","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jac\/34.6.955","article-title":"Detection of fosfomycin resistance by the polymerase chain reaction and Western blotting","volume":"34","author":"Garc\u00eda","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0170","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1128\/JB.00748-09","article-title":"The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa","volume":"191","author":"Casta\u00f1eda-Garc\u00eda","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1469-0691.2004.01057.x","article-title":"Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data","volume":"11","author":"Al\u00f3s","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.08.012_bib0180","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1128\/AAC.00402-12","article-title":"Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms","volume":"56","author":"Neuner","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003192?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915003192?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T19:54:11Z","timestamp":1537300451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915003192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0924857915003192"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}